SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-452822
Filing Date
2014-12-23
Accepted
2014-12-23 16:42:35
Documents
3
Period of Report
2014-12-17
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d842482d8k.htm 8-K 22127
2 EX-3.1 d842482dex31.htm EX-3.1 21889
3 EX-3.2 d842482dex32.htm EX-3.2 112006
  Complete submission text file 0001193125-14-452822.txt   157523
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 141307381
SIC: 2834 Pharmaceutical Preparations